AWIIX
Price
$15.92
Change
-$0.14 (-0.87%)
Updated
Jun 13 closing price
Net Assets
673.52M
RLBCX
Price
$35.72
Change
+$0.14 (+0.39%)
Updated
Jun 12 closing price
Net Assets
245.62B
Interact to see
Advertisement

AWIIX vs RLBCX

Header iconAWIIX vs RLBCX Comparison
Open Charts AWIIX vs RLBCXBanner chart's image
CIBC Atlas Income Opportunities Instl
Price$15.92
Change-$0.14 (-0.87%)
VolumeN/A
Net Assets673.52M
American Funds American Balanced R3
Price$35.72
Change+$0.14 (+0.39%)
VolumeN/A
Net Assets245.62B
AWIIX vs RLBCX Comparison Chart
Loading...
View a ticker or compare two or three
VS
AWIIX vs. RLBCX commentary
Jun 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AWIIX is a Buy and RLBCX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RLBCX has more cash in the bank: 246B vs. AWIIX (674M). AWIIX pays higher dividends than RLBCX: AWIIX (1.78) vs RLBCX (1.63). AWIIX was incepted earlier than RLBCX: AWIIX (11 years) vs RLBCX (23 years). RLBCX (0.89) is less costly to investors than AWIIX (0.69). RLBCX is a more actively managed with annual turnover of: 44.00 vs. AWIIX (19.00). RLBCX has a lower initial minimum investment than AWIIX: RLBCX (250) vs AWIIX (250000). RLBCX annual gain was more profitable for investors over the last year : 6.48 vs. AWIIX (4.45). AWIIX return over 5 years is better than : 46.80 vs. RLBCX (37.71).
AWIIXRLBCXAWIIX / RLBCX
Total Expense Ratio0.690.8978%
Annual Report Gross Expense Ratio0.690.8978%
Fund Existence11 years23 years-
Gain YTD2.2935.20744%
Front LoadN/AN/A-
Min. Initial Investment250000250100,000%
Min. Initial Investment IRAN/AN/A-
Net Assets674M246B0%
Annual Yield % from dividends1.781.63109%
Returns for 1 year4.456.4869%
Returns for 3 years28.8431.9490%
Returns for 5 years46.8037.71124%
Returns for 10 years100.5057.05176%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FDYNX144.29N/A
N/A
Franklin DynaTech C
TCAGX8.51N/A
N/A
Timothy Plan Small/Mid Cap Growth Cl C
NBHAX14.61N/A
N/A
Neuberger Berman Equity Income A
GIRMX25.63N/A
N/A
Goldman Sachs Emerging Markets Eq Inv
EPGIX13.85N/A
N/A
EuroPac Gold I